益气化瘀中药配合自凝刀治疗子宫肌瘤的临床分析附：自凝刀治疗子宫肌瘤分析进展

《益气化瘀中药配合自凝刀治疗子宫肌瘤的临床分析附：自凝刀治疗子宫肌瘤分析进展》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。

1、中文摘要目的：比较自凝刀组、自凝刀术后加中药组、自凝刀术后加米非司酮组分别治疗子宫肌瘤的临床疗效，观察自凝刀术后加用益气化瘀中药是否可加速瘤体吸收、改善患者症状、减少自凝刀术后的并发症，以评价中药干预的优势，探索子宫肌瘤保守性治疗的新方案。方法：选择符合标准的子宫肌瘤患者33名，随机分成自凝刀组12例、自凝刀+中药组15例、自凝刀+米非司酮组6例。自凝刀组术后不用药；自凝刀+中药组术后服用中药茂桂消癥散免煎颗粒3个月；自凝刀+米非司酮组术后服用米非司酮3个月。治疗1个月、3个月随访，复查B超和妇检，询问病人相

2、关症状，记录子宫肌瘤体积的变化。3个月疗程全部结束时进行安全性检查。痊愈病人术后半年随访，复查B超和妇检，了解肌瘤复发情况。结果：1缩瘤疗效：治疗1个月后三组比较P>0.05；治疗3个月自凝刀加中药组与自凝刀组比较P<0.05,自凝刀加中药组与自凝刀加米非司酮组比较P>0.05o2证候疗效：自凝刀组及自凝刀加中药组术后1个月、3个月证候积分与治疗前比较均P<0.01o治疗1个月后自凝刀加中药组对月经量、经质、腰紙疼痛、小腹坠胀等症状的疗效优于自凝刀组，且与自凝刀组比较可明显缩短术后排液时间；3个月两组中医证候

3、疗效比较P>0.05o结论：本临床研究初步显示自凝刀术后加用益气化瘀中药有加速瘤体吸收、改善患者症状、减少自凝刀术后并发症的作用。尖键词：中医药自凝刀子宫肌瘤临床研究AbstractObjective:Fromcomparingthecurativeeffectofradiofrequencyablation(RFA)group>radiofrequencyablationwithtraditionalChinesemedicine(RFA+TCM)groupandradiofrequencyablation

4、withRu486(RFA+Ru486)grouponhysteromyoma,observingwhetherradiofrequencyablationwithtraditionalChinesemedicinewhichcantonifyqiandremovebloodstasiscanacceleratetheabsorptionoftumor>improvepatient'ssymptomanddecreasethecomplicationsafterthesurgery,toevaluatethe

5、advantagesofRFA+TCMgroupandexploreanewconservativetreatmentwayofhysteromyoma.Methods:Dividethirtythreehysteromyomapatientswhomeetthecriterionintothreegroupsatrandom,twelvepatientstreatedbyRFA,fifteenpatientstreatedbyTCMafterRFA'stherapy,sixpatientstreatedby

6、Ru486afterRFA'stherapy.AtfirstallofthepatientsreceiveRFAtreatment,afterthesurgery,RFAgroupdon^ttakeanymedcine;RFA+TCMgrouptake"QiGuiXiaoZheng”granulesforthreemonths;RFA+Ru486grouptakeRu486tabletsforthreemonths.WhentheyrecheckedbyBmodeultrasoundandgynecologi

7、calexaminationafteronemonth>threemonthstherypy,weinquiretheirsymptomsandrecordthechangesofhysteromyoma"scubage.Attheendofthreemonths'therapy,allofthepatientsacceptsafeexamination.Thewell-healedpatientswillbeobservedforsixmonthsandrecheckedBmodeultrasoundand

8、gynecologicalexamination,inordertoknowtherecurrenceofhysteromyoma.Results:1effectoftumorouscubage'sminification:Comparingthethreegroupsdifferenceontumorouscubage'sminification:ononemonthP>0.05;onthreem